About Komal Bhattar
Komal's passion for the stock market and financial analysis led her to pursue investment research as a career. Her fundamental approach to analyzing stocks helps investors identify the best investment opportunities.
She earned a bachelor's degree in accounting and finance from St. Xavier’s College, and she is currently pursuing a graduate degree in Chartered Accountancy.
Recent Articles By Komal Bhattar
2 Stocks Under $50 You Shouldn’t Ignore in Q4
Sky-rocketing inflation and the Fed’s hawkish tilt have led to an economic slowdown. However, a decent start to the corporate earnings season is lifting investors’ optimism. And we think it will not be wise for investors to ignore fundamentally solid stocks such as Pfizer (PFE) and Kroger (KR), currently trading under $50. Keep reading…
Buy These 2 Growth Stocks Before They Boom
The red-hot inflation and the Fed’s hawkish stance are raising the possibility of a recession. However, historical trends suggest that the market could experience a rebound later this month or early next month. So, we think it could be wise to invest in growth stocks Teva Pharmaceutical (TEVA) and Forrester Research (FORR), which are well-positioned to ride the market’s potential rebound. Keep reading…
3 Names It Wouldn’t Hurt to Stock up On
Despite the Fed’s continued hawkish stance, the September inflation report came in hotter than expected, raising the possibility of another aggressive interest rate hike in November. However, it could be smart to keep investing in quality stocks to benefit from their rebound. We think Microsoft (MSFT), Eli Lilly (LLY), and CVS Health (CVS) could be safe investments, given their stability and robust rebound potential. Keep reading…
3 Upgraded Stocks to Consider Buying This Week
The red-hot inflation is increasing the odds of continued rate hikes by the Fed. Since the market is expected to remain under pressure on recession fears, it could be wise to invest in fundamentally sound stocks Comcast Corporation (CMCSA), GSK (GSK), and Masonite International (DOOR), which have been recently upgraded in our proprietary rating system. Read on…
These 2 Stocks Will Be Winners Over the Long Term
Inflation came in more than expected in September, raising the chances of a fourth 75-bps rate hike by the Fed at the year-end. The Fed’s aggressive rate hikes are leading the economy to a recession. However, investors should focus on long-term strategies to offset the current situation. We think fundamentally solid stocks Cigna Corporation (CI) and SX Corporation (CSX) look poised to deliver steady returns over the long term. Keep reading…
3 Dividend Stocks to Increase Your Income
Inflation increased more than expected in September despite the rate hikes. The stubbornly high inflation cements the case for further hawkishness from the Fed. Amid rising recession worries, we think dividend stocks Eli Lilly (LLY), APA Corporation (APA), and Bluegreen Vacations (BVH), with stable dividend-paying records, could be ideal additions to your portfolio to ensure a stable income stream. Keep reading…
2 Stocks You Shouldn’t Buy During a Market Downturn
Stock market volatility is rife due to the Fed’s continued rate hikes and widespread recession fear among investors. Moreover, the ongoing Russia-Ukraine war and other macroeconomic issues are hindering global growth prospects. Given the market turmoil, we think investors should steer clear of Royal Caribbean Cruises (RCL) and Carvana (CVNA), considering their weak fundamentals. Read on…
5 Stocks Under $50 to Buy This Week
Despite widespread recession concerns, Jim Cramer believes that the market could see an outsized rally in the near term as per historical trends. Given this backdrop, we think investors should load up Pfizer (PFE), Stellantis (STLA), APA Corporation (APA), Ryerson Holding (RYI), and Forrester Research (FORR), which are trading under $50, considering their fundamental strength. Read on…
2 Stocks That Could Help You Fund Your Retirement
The stock market is experiencing a broad sell-off due to the Fed’s hawkish rate hikes and rising recession odds. As healthcare stocks are considered safe haven amid market turbulence, we think fundamentally sound Johnson & Johnson (JNJ) and Pfizer (PFE), which also have a significant dividend-paying record, could be solid investments for your retirement. Keep reading…